NCT00006379
- Conditions
- Amyloidosis, Anemia, Anemia, Refractory, +100 more
- Locations
-
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Clinical trial condition
Monoclonal Gammopathy of Undetermined Significance
Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.
82 public trials
19 recruiting studies
Monoclonal Gammopathy of Undetermined Significance trial results
NCT00006362
- Conditions
- Amyloidosis, Blood Protein Disorders, Burkitt Lymphoma, +50 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States
NCT00661999
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +72 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00002504
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Bloomington Hospital Bloomington, Indiana, United States
- St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States
- Bergan Mercy Medical Center Omaha, Nebraska, United States
NCT00003331
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Kaplan Cancer Center New York, United States
NCT00005804
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00003082
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
Active, Not Recruiting
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
NCT05831358
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Active, Not Recruiting
Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy
NCT05939037
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- University Medical Center Utrecht Utrecht, Netherlands
Active, Not Recruiting
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
NCT04850846
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Dana-Farber at Brighton Brighton, Massachusetts, United States
- Dana-Farber at Merrimack Valley Methuen, Massachusetts, United States